Immediate Impact
4 from Science/Nature 75 standout
Citing Papers
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
2024 Standout
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Works of P.J. Barter being referenced
Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
2009
The rationale for using apoA‐I as a clinical marker of cardiovascular risk
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| P.J. Barter | 534 | 103 | 297 | 166 | 13 | 726 | |
| Rajesh Movva | 356 | 48 | 289 | 199 | 14 | 711 | |
| Simone L. Verweij | 350 | 79 | 120 | 199 | 14 | 683 | |
| Howard M. Monroe | 315 | 40 | 267 | 130 | 6 | 581 | |
| Joel Kahn | 484 | 64 | 220 | 217 | 11 | 774 | |
| M.L. Nava | 448 | 34 | 169 | 121 | 11 | 633 | |
| T. Bourcier | 317 | 47 | 352 | 81 | 11 | 725 | |
| B Kishino | 408 | 29 | 236 | 126 | 28 | 744 | |
| Carol L. Heideman | 514 | 37 | 190 | 121 | 12 | 759 | |
| Rhiannon Dodge | 240 | 41 | 212 | 175 | 10 | 593 | |
| Fatima Akdim | 418 | 36 | 235 | 298 | 22 | 847 |
All Works
Loading papers...